![](/img/cover-not-exists.png)
Two Year SAVE Outcomes: 2.0 mg Ranibizumab for Recalcitrant Neovascular AMD
Wykoff, Charles C., Brown, David M., Croft, Daniel E., Wong, Tien P.Volume:
120
Language:
english
Journal:
Ophthalmology
DOI:
10.1016/j.ophtha.2013.06.030
Date:
September, 2013
File:
PDF, 340 KB
english, 2013